{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:35:02Z","timestamp":1794335702965,"version":"4.9.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Early-stage cervical cancer generally has a favorable prognosis with treatment, yet recurrence remains a significant risk for a subset of patients. Identifying reliable prognostic factors can help refine risk stratification, optimize follow-up strategies, and guide adjuvant therapy decisions. This meta-analysis evaluates the association between key prognostic factors\u2014tumor diameter, HPV status, depth of invasion, LVSI status, and positive lymph nodes\u2014and recurrence risk in early-stage cervical cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>A systematic search of PubMed, Embase, Cochrane Library, and Scopus was conducted to identify studies assessing the relationship between prognostic factors and recurrence in early-stage cervical cancer. Studies meeting predefined inclusion criteria were selected, and data were extracted on patient demographics, tumor characteristics, and recurrence outcomes. The NOS was used to assess study quality. Pooled ORs with 95% CIs were calculated using both fixed-effects and random-effects models, with heterogeneity and publication bias assessed through I\u00b2 statistics and funnel plot analysis, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 10 studies were included in the meta-analysis. Tumor diameter &amp;gt;4\u2005cm (OR\u2009=\u20092.49; 95% CI: 1.69\u20133.69), depth of invasion &amp;gt;1\/2 (OR\u2009=\u20092.82; 95% CI: 1.66\u20134.80), LVSI positivity (OR\u2009=\u20092.54; 95% CI: 1.36\u20134.73), and positive lymph nodes (OR\u2009=\u20092.86; 95% CI: 1.99\u20134.11) were all significantly associated with an increased risk of recurrence. However, HPV-positive status showed no consistent association with recurrence risk (OR\u2009=\u20092.12; 95% CI: 0.31\u201314.52), likely due to high heterogeneity among the studies (I\u00b2\u2009=\u200986%). Sensitivity analyses confirmed the robustness of the results, and publication bias was minimal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This meta-analysis identified tumor diameter &amp;gt;4\u2005cm, depth of invasion &amp;gt;1\/2, LVSI positivity, and positive lymph nodes as significant prognostic factors for recurrence in early-stage cervical cancer. These findings underscore the importance of comprehensive assessment in clinical practice to better identify high-risk patients who may benefit from intensified monitoring or adjuvant therapies. Further research, particularly on the role of HPV status, is needed to enhance the predictive accuracy of recurrence risk models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD42024599867<\/jats:ext-link>, PROSPERO CRD42024599867.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fsurg.2025.1588558","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:31:17Z","timestamp":1750311077000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive factors for postoperative recurrence in early cervical cancer patients: a meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Weili","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suli","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1186\/s12885-024-12743-3","article-title":"Cervical cancer screening practice and associated factors among female health care professionals in Ethiopia 2024: a systematic review and meta-analysis","volume":"24","author":"Lakew","year":"2024","journal-title":"BMC Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"100477","DOI":"10.1016\/j.jcpo.2024.100477","article-title":"Cervical cancer prevention in Southern Africa: a review of national cervical cancer screening guidelines in the Southern African development community","volume":"40","author":"Adams","year":"2024","journal-title":"J Cancer Policy"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.3390\/healthcare11162273","article-title":"Cervical cancer screening recommendations: now and for the future","volume":"11","author":"Rayner","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.3390\/cancers12123814","article-title":"Effect of radiotherapy in addition to surgery in early stage endometrial cancer: a population-based study","volume":"12","author":"Medenwald","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/jnci\/djac119","article-title":"Genomic determinants of early recurrences in low-stage, low-grade endometrioid endometrial carcinoma","volume":"114","author":"Safdar","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"B6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000503149","article-title":"Influence of the new FIGO classification for cervical cancer on patient survival: a retrospective analysis of 265 histologically confirmed cases with FIGO stages IA to IIB","volume":"98","author":"de Gregorio","year":"2020","journal-title":"Oncology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/jcm11133645","article-title":"Risk factors for recurrence of borderline ovarian tumours after conservative surgery and impact on fertility: a multicentre study by the francogyn group","volume":"11","author":"Ozenne","year":"2022","journal-title":"J Clin Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1136\/ijgc-2022-003971","article-title":"Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification","volume":"32","author":"Bae","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ygyno.2020.06.508","article-title":"Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: a multi-institutional study","volume":"159","author":"Casarin","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1006\/gyno.1994.1140","article-title":"Prognostic factors and relapse patterns in early-stage cervical carcinoma after brachytherapy and radical hysterectomy","volume":"53","author":"Gerdin","year":"1994","journal-title":"Gynecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0166311","DOI":"10.1371\/journal.pone.0166311","article-title":"High-grade tumor budding stratifies early-stage cervical cancer with recurrence risk","volume":"11","author":"Huang","year":"2016","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.3390\/healthcare11222942","article-title":"Surgical treatment for early cervical cancer in the HPV era: state of the art","volume":"11","author":"Palumbo","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"113994","DOI":"10.1016\/j.ejogrb.2025.113994","article-title":"Impact of human papillomavirus 9-valent vaccine on viral clearance after surgical treatment: a single-center retrospective observational study","volume":"310","author":"Palumbo","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"964","DOI":"10.4143\/crt.2017.346","article-title":"The prognostic impact of the number of metastatic lymph nodes and a new prognostic scoring system for recurrence in early-stage cervical cancer with high risk factors: a multicenter cohort study (KROG 15-04)","volume":"50","author":"Kwon","year":"2018","journal-title":"Cancer Res Treat"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12905-023-02853-8","article-title":"Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Womens Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1525-1438.1999.99037.x","article-title":"Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy","volume":"9","author":"Maneo","year":"1999","journal-title":"Int J Gynecol Cancer"},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejogrb.2012.06.026","article-title":"Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study","volume":"165","author":"Serati","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11065-016-9319-z","article-title":"A guide to conducting a meta-analysis","volume":"26","author":"Cheung","year":"2016","journal-title":"Neuropsychol Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: guidance in the cochrane handbook for systematic reviews of interventions, 2nd edition","volume":"44","author":"Cumpston","year":"2022","journal-title":"J Public Health (Oxf)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000001195","article-title":"A comparison of the clinicopathological features and genetic alterations in stage II\/III gastric cancer with no recurrence, early recurrence and late recurrence after curative surgery","author":"Chiu","year":"2024","journal-title":"J Chin Med Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.medj.2021.11.001","article-title":"Liquid biopsies for residual disease and recurrence","volume":"2","author":"Wan","year":"2021","journal-title":"Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1159\/000541078","article-title":"Enucleation for sporadic nonfunctioning pancreatic neuroendocrine tumors larger than 2 centimeters is associated with equivalent morbidity and survival compared to smaller tumors: a multi-institutional study","volume":"114","author":"Karam","year":"2024","journal-title":"Neuroendocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1158\/0008-5472.CAN-17-0032","article-title":"Epithelial-to-mesenchymal and mesenchymal-to-epithelial transition in mesenchymal tumors: a paradox in sarcomas?","volume":"77","author":"Sannino","year":"2017","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1509195","DOI":"10.3389\/fimmu.2024.1509195","article-title":"Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy","volume":"15","author":"Yan","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/cas.14283","article-title":"ATP6l promotes metastasis of colorectal cancer by inducing epithelial-mesenchymal transition","volume":"111","author":"Wang","year":"2020","journal-title":"Cancer Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00405-017-4828-9","article-title":"Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology","volume":"275","author":"Kim","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e2537","DOI":"10.1002\/rmv.2537","article-title":"Human papillomavirus infection: epidemiology, biology, host interactions, cancer development, prevention, and therapeutics","volume":"34","author":"Wolf","year":"2024","journal-title":"Rev Med Virol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4238\/gmr16039742","article-title":"Synergic effect of oral contraceptives, GSTP1 polymorphisms, and high-risk HPV infection in development of cervical lesions","volume":"16","author":"Chagas","year":"2017","journal-title":"Genet Mol Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13148-017-0397-4","article-title":"Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients","volume":"9","author":"Lind","year":"2017","journal-title":"Clin Epigenetics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5525741","DOI":"10.1155\/2024\/5525741","article-title":"Parotid gland metastases of cutaneous squamous cell carcinoma of the head: occult metastases occurrence and their late manifestation","volume":"2024","author":"Horakova","year":"2024","journal-title":"Int J Clin Pract"},{"key":"B31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.urology.2016.03.058","article-title":"Occult metastases in pelvic lymphadenectomy specimens from patients with urothelial carcinoma of the bladder","volume":"94","author":"Gordetsky","year":"2016","journal-title":"Urology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/IGC.0b013e31822fa8bb","article-title":"Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix","volume":"22","author":"Singh","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3892\/mco.2014.465","article-title":"Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer","volume":"3","author":"Wang","year":"2015","journal-title":"Mol Clin Oncol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1588558\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T05:31:17Z","timestamp":1750311077000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2025.1588558\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":33,"alternative-id":["10.3389\/fsurg.2025.1588558"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2025.1588558","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"1588558"}}